Skip to main content
. Author manuscript; available in PMC: 2015 Dec 1.
Published in final edited form as: J Dual Diagn. 2014;10(4):177–186. doi: 10.1080/15504263.2014.961882

Table 4.

Baseline Clinical Characteristics and Comorbidity in Substance-Induced Psychosis Group (n=168)

Male
(n=125)		 Female
(n=43)		 p-value
Clinical Characteristics M ± SD M ± SD
    Premorbid Adjustment .33±.17 .26±.16 <.05
    Positive Symptoms 14.1±5.4 14.8±5.4 NS
    Negative Symptoms 11.8±4.7 11.6±4.8 NS
    General Psychopathology Symptoms 28.2±6.9 29.6±6.8 NS
    Depression Symptoms 10.0±3.7 11.0±4.4 NS
    Unawareness of Symptoms 6.1±9.4 3.9±5.1 NS
    Misattribution of Symptoms 5.2±5.7 4.1±4.5 NS
    Age Onset of Regular Drug Use 17.9±6.0 20.8±7.3 <.05
Comorbidity n (%) n (%)
    Antisocial Personality Disorder 24 (19.2) 4 (9.3) NS
    Borderline Personality Disorder 15 (12.0) 8 (18.6) NS
    Posttraumatic Stress Disorder 21 (16.8) 15 (34.9) <.02
    Drug Dependence 78 (62.4) 28 (65.1) NS

Note. NS = not significant.